Our top pick for
ICF International Inc is a consulting services business based in the US. ICF International shares (ICFI) are listed on the NASDAQ and all prices are listed in US Dollars. ICF International employs 7,500 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$98.10|
|52-week range||$63.18 - $101.92|
|50-day moving average||$92.27|
|200-day moving average||$91.72|
|Wall St. target price||$113.80|
|Dividend yield||$0.56 (0.58%)|
|Earnings per share (TTM)||$3.63|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-20)||1.59%|
|1 month (2021-09-27)||9.30%|
|3 months (2021-07-27)||9.58%|
|6 months (2021-04-27)||5.78%|
|1 year (2020-10-27)||44.88%|
|2 years (2019-10-25)||17.05%|
|3 years (2018-10-26)||33.16%|
|5 years (2016-10-27)||111.42%|
Valuing ICF International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ICF International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ICF International's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 27x. In other words, ICF International shares trade at around 27x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
ICF International's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.881. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ICF International's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
ICF International's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $157.9 million.
The EBITDA is a measure of a ICF International's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.6 billion|
|Operating margin TTM||7.96%|
|Gross profit TTM||$534.5 million|
|Return on assets TTM||4.8%|
|Return on equity TTM||9.39%|
|Market capitalisation||$1.8 billion|
TTM: trailing 12 months
There are currently 203,541 ICF International shares held short by investors – that's known as ICF International's "short interest". This figure is 1.8% up from 199,876 last month.
There are a few different ways that this level of interest in shorting ICF International shares can be evaluated.
ICF International's "short interest ratio" (SIR) is the quantity of ICF International shares currently shorted divided by the average quantity of ICF International shares traded daily (recently around 57988.888888889). ICF International's SIR currently stands at 3.51. In other words for every 100,000 ICF International shares traded daily on the market, roughly 3510 shares are currently held short.
However ICF International's short interest can also be evaluated against the total number of ICF International shares, or, against the total number of tradable ICF International shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ICF International's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 ICF International shares in existence, roughly 10 shares are currently held short) or 0.0112% of the tradable shares (for every 100,000 tradable ICF International shares, roughly 11 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ICF International.
Find out more about how you can short ICF International stock.
Dividend payout ratio: 11.72% of net profits
Recently ICF International has paid out, on average, around 11.72% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.57% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), ICF International shareholders could enjoy a 0.57% return on their shares, in the form of dividend payments. In ICF International's case, that would currently equate to about $0.56 per share.
While ICF International's payout ratio might seem low, this can signify that ICF International is investing more in its future growth.
ICF International's most recent dividend payout was on 12 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 8 September 2021 (the "ex-dividend date").
Over the last 12 months, ICF International's shares have ranged in value from as little as $63.1803 up to $101.9202. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ICF International's is 0.6265. This would suggest that ICF International's shares are less volatile than average (for this exchange).
ICF International, Inc. provides management, marketing, technology, and policy consulting and implementation services to government and commercial clients in the United States and internationally. The company researches critical policy, industry, stakeholder issues, trends, and behaviors; measures and evaluates results and their impact; and provides strategic planning and advisory services to its clients on how to navigate societal, market, business, communication, and technology challenges. It also identifies, defines, and implements policies, plans, programs, and business tools through a range of standard and customized methodologies for its clients; conducts survey research; collects and analyzes various data to understand critical issues and options for its clients; and provides actionable business intelligence, as well as information and data management solutions that allow integrated and purpose-driven data usage. In addition, the company provides solutions to optimize the customer and citizen experience; modernizes IT systems; and cyber security solutions that support the range of cyber security missions and protect IT infrastructures in the face of relentless threats, as well as designs, develops, and implements technology systems and business tools that are principal to its clients' mission or business performance. Further, it informs and engages its clients' constituents, customers, and employees through public relations, branding and marketing, multichannel and strategic communications, and reputation issues management. The company serves energy, environment, and infrastructure; health, education, and social programs; safety and security; and consumer and financial markets.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.